P4A’s propriety insights platform

MAXConnect, our global Payer & KOL network, is hand selected based on your unique situation. MAXConnect is your strategic guide to enable more effective PRMA decision making for orphan drugs and ATMPs. Whether you prefer one-to-one in-depth discussions, ad-boards or online surveys, with MAXConnect we’ve got you covered

P4A understand the myriad of challenges clients face obtaining valuable and relevant expert payer insights.

In recognition of these needs P4A developed

Connect by name, connect by nature

Our expert network covers the globe, supporting rare
disease specialism throughout the following key regions.

No matter where you want to launch we’ve got you covered

Through MAXconnect P4A facilitate
two types of specialist engagements.


Formal engagements involve Regulatory and HTA agencies.

We shape, guide andprocess the information and outcomes you receive from HTA and Regulatory bodies.


Informal engagements are arranged using our global panel of ex-payers.

Our curated network of experts provide industry leading knowledge with flexibility, variety, speed precision and excellence.

Interested in joining our global network?
Read more

More information on joining MAXconnect
Contact us